Navigation Links
HIV antibodies block infection by reservoir-derived virus in laboratory study
Date:8/26/2014

WHAT:

A laboratory study led by scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), lends further weight to the potential effectiveness of passive immunotherapy to suppress HIV in the absence of drug treatment. Passive immunotherapy for HIV is an experimental strategy that involves periodically administering broadly neutralizing HIV-specific antibodies (bNAbs) to control the virus. It would be advantageous to control HIV without antiretroviral drugs because of their cost, the potential for cumulative toxicities from lifelong therapy, and the difficulties some patients have adhering to drug regimens and tolerating certain drugs.

Although bNAbs have proven effective at blocking infection by various strains of HIV in the laboratory, their effect on HIV in humans, and particularly on the virus particles that hide in immune cells (called latent viral reservoirs), has been unknown.

In this study, NIH scientists obtained HIV from the latent reservoirs of 29 infected people in whom antiretroviral therapy fully inhibited viral replication. In the laboratory, the researchers found that several bNAbsparticularly PGT121, VRC01 and VRC03 effectively blocked HIV from entering the CD4+ T cells obtained from uninfected healthy donors. In addition, the scientists demonstrated in the laboratory that these antibodies could completely block HIV replication in CD4+ T cells obtained from infected individuals receiving antiretroviral therapy.

The researchers conclude that passive immunotherapy involving bNAbs individually or in combination may control HIV in the absence of antiretroviral therapy. A number of clinical trials are already underway or planned to test this hypothesis.


'/>"/>

Contact: Laura S. Leifman
laura.sivitz@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert  

Page: 1

Related medicine news :

1. No correlation between baby formulas and development of diabetes-associated autoantibodies
2. Antibodies from the desert as guides to diseased cells
3. NIH grantees sharpen understanding of antibodies that may cut risk of HIV infection
4. NIH scientists find mechanism that helps HIV evade antibodies, stabilize key proteins
5. Monoclonal Antibodies Market in Gastric and Esophageal Cancers to Reach USD 766 Mln by 2019, Says GBI Research in Its Report Available at MarketPublishers.com
6. Higher mortality in postmenopausal women with RA and anti-CCP antibodies
7. Maine Biotechnology Services-USDA-ARS Partnership Provides Monoclonal Antibodies to Aid in the Containment of Rift Valley Fever Virus
8. Ben-Gurion U. and Sorrento Therapeutics sign agreement to develop anti-hepatitis C virus antibodies
9. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
10. Monoclonal Antibodies Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
11. Research reveals how antibodies neutralize mosquito-borne virus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV antibodies block infection by reservoir-derived virus in laboratory study
(Date:2/13/2019)... ... February 13, 2019 , ... Dr. Jig Patel and ... Muizz Merchant, an exceptionally talented and knowledgeable dentist from St. Louis, MO, ... dental techniques, such as CEREC same-day dentistry, root canals and emergency treatment. Dr. Patel, ...
(Date:2/13/2019)... (PRWEB) , ... February 13, 2019 , ... Surgery that ... effective and safe treatment for obstructive sleep apnea (OSA), resulting in benefits that include ... risk, according to a new study. , MMA should be regarded as the preferred ...
(Date:2/13/2019)... BEACH GARDENS, Fla. (PRWEB) , ... February 13, ... ... their exclusivity, and luxurious lifestyle publication is privileged to present Dr. David A. ... Living partnership. , Haute Beauty offers a prominent collective of leading doctors. The ...
(Date:2/12/2019)... , ... February 12, 2019 , ... ... interactive workshop from FDAnews and Ombu Enterprises**, Feb. 19-20, 2019, Atlanta, GA , ... Management: Prepare for the Winds of Change on Jan. 22 , Risk management ...
(Date:2/12/2019)... ... February 12, 2019 , ... Accreditation Commission ... Island Partnership for Home Care. This agreement allows Rhode Island Partnership for Home ... Duty Accreditation services, as well as discounts on ACHCU educational resources that help ...
Breaking Medicine News(10 mins):
(Date:2/14/2019)... ... 2019 , ... In this month’s NEPC Education Interview ... A. Smith speaks with Christopher Saldaña, Doctoral Student Researcher at the National Education ... in the marketing of educational resources to schools. , Along with his co-authors, ...
(Date:2/14/2019)... ... February 14, 2019 , ... ... focuses on developing and commercializing minimally-invasive, innovative spinal technologies, today announced a ... Surgical name better emphasizes our commitment to delivering new, cutting-edge, surgical solutions ...
(Date:2/13/2019)... ... 2019 , ... Entomol’s breakthrough safe and effective all natural ... release and sale within the state. California has the most stringent regulatory approval ... This registration opens the door for wholesale/retail and military sales opportunities within the ...
Breaking Medicine Technology: